Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5% [1] - The Non-IFRS net profit reached 3.57 billion yuan, showing a year-on-year increase of 35% [1] - The annual active user count surpassed 200 million, with an average of over 500,000 daily consultations at JD Internet Hospital [1] Group 1: Service Expansion and Specialization - JD Health has enhanced its "medical, testing, diagnosis, and medication" service loop, focusing on specialized fields in internet hospitals to meet diverse health needs [1] - The company has established a five-specialty system centered on dermatology, mental health, traditional Chinese medicine, oncology, and urology, providing tailored treatment plans to over 20 million patients in dermatology [1] - JD Health launched the first internet-based "rare skin disease diagnosis and treatment zone" and collaborated with universities to create a mental health service system for college students [1] Group 2: Home Healthcare and AI Integration - JD Health continues to solidify its leading position in home healthcare services, expanding its service offerings to 64 items across 7 categories, including home care and rehabilitation [2] - The company has broadened its rapid testing service network, providing over 160 types of rapid testing services to users in 23 cities [2] - JD Health introduced a series of AI products for online scenarios, including AI doctors, pharmacists, nutritionists, and mental health consultants, becoming the largest platform for AI medical professionals in the industry [2] - The company has developed a comprehensive AI health service matrix, integrating AI doctors with various professional service roles to advance the large-scale application of AI in internet healthcare [2]

Core Viewpoint - JD Health is experiencing a significant rebound in revenue growth, with a 24.5% year-on-year increase in the first half of 2025, indicating a return to double-digit growth after a period of slower performance [1][2]. Group 1: Financial Performance - In the first half of 2025, JD Health reported revenue of 35.3 billion yuan, a 24.5% increase compared to the previous year, and a net profit of 3.57 billion yuan, up 35% [1]. - The revenue growth is notably higher than the 4.35% increase seen in the first half of 2024, marking an improvement of over 20 percentage points [1]. - The core business of "pharmaceutical and health product sales" generated 29.33 billion yuan in the first half of 2025, reflecting a nearly 25% year-on-year growth [2]. Group 2: Market Context - The overall retail pharmacy market is contracting, with 14,000 stores closing in the fourth quarter of 2024, accounting for over one-third of the annual total, leading to a decline in the number of retail pharmacy stores to below 700,000 by the first quarter of 2025 [3]. - Despite the market contraction, JD Health's collaboration with third-party pharmacies has accelerated, with over 150,000 partners by the end of June 2025, an increase of more than 50,000 from the end of 2024, representing a nearly 90% year-on-year growth [4]. Group 3: Advertising and Marketing - Revenue from "platform, advertising, and other services" reached 5.96 billion yuan in the first half of 2025, showing a growth of over 30% [4]. - JD Health has increased its sales expenses to 1.8 billion yuan in the first half of 2025, a rise of 28.8%, primarily due to increased promotional and advertising expenditures [6][7]. Group 4: Business Expansion - JD Health is exploring new business avenues, including the medical beauty sector, with the opening of its first offline medical beauty clinic in Beijing in July 2025, and plans for a second clinic in Beijing's Guomao area [8].

Core Viewpoint - JD Health reported strong financial performance for the first half of 2025, with significant growth in revenue and profit driven by the sales of pharmaceutical and health products [1] Financial Performance - The company achieved revenue of 35.29 billion yuan, representing a year-on-year growth of 24.5% [1] - Operating profit reached 2.13 billion yuan, marking a substantial increase of 105.5% year-on-year [1] - Net profit attributable to shareholders was 2.60 billion yuan, reflecting a year-on-year growth of 27.45% [1] Business Segments - JD Health's revenue growth was primarily fueled by the sales of pharmaceutical and health products, which increased by 22.7% to 29.3 billion yuan compared to the same period last year [1] - The company launched over 30 innovative drugs online in the first half of the year, including weight loss drug Xin'ermei and hypertension treatment drug Xinchao Tuo [1] User Engagement and Platform Growth - As of June 30, 2025, the number of merchants on JD Health's platform exceeded 150,000, an increase of over 50,000 since December 31, 2024 [1] - The annual active user count surpassed 200 million, with an average of over 500,000 consultations per day in the first half of the year [1]

Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5% [1] - The Non-IFRS net profit reached 3.57 billion yuan, with a year-on-year increase of 35% [1] - The annual active user count surpassed 200 million, with an average of over 500,000 daily consultations at JD Internet Hospital [1] Group 1: Service Expansion and Specialization - JD Health has enhanced its "medical, testing, diagnosis, and medication" service loop, focusing on specialized fields in internet hospitals to meet diverse health needs [1] - The company has established five core specialty systems in dermatology, mental health, traditional Chinese medicine, oncology, and andrology, providing personalized treatment plans to over 20 million patients in dermatology [1][2] - JD Health has launched the first internet-based "rare skin disease diagnosis and treatment zone" and developed a mental health service system for university students in collaboration with multiple universities [1][2] Group 2: Home Healthcare and AI Integration - JD Health continues to solidify its leading position in home healthcare services, expanding its service offerings to 64 items across seven categories, including home care and rehabilitation [2] - The company has broadened its rapid testing service network, providing over 160 types of rapid testing services to users in 23 cities [2] - JD Health has introduced a series of AI products for online scenarios, including AI doctors, pharmacists, nutritionists, and psychological counselors, as well as digital avatars for expert doctors [2] - The JD Internet Hospital has launched over 500 expert doctor AI avatars, making it the largest platform in terms of AI doctor quantity and service scale in the industry [2]

Core Insights - JD Health reported a total revenue of RMB 35.3 billion for the first half of 2025, representing a year-on-year growth of 24.5%, with a Non-IFRS net profit of RMB 3.57 billion, up 35% [1] - The company has surpassed 200 million annual active users and has over 150,000 third-party merchants on its platform as of June 30, 2025 [1] - JD Health is enhancing its supply chain capabilities and solidifying its position as the "first entry point for online health consumption" [1][3] Revenue and User Growth - JD Health's revenue for the first half of 2025 reached RMB 35.3 billion, a 24.5% increase year-on-year [1] - The Non-IFRS net profit for the same period was RMB 3.57 billion, reflecting a 35% growth [1] - The annual active user count exceeded 200 million, with over 150,000 third-party merchants collaborating on the platform [1][3] Supply Chain and Product Offerings - The company is strengthening its omni-channel supply chain model, collaborating with leading pharmaceutical companies to expand product offerings [3] - Over 30 innovative drugs were launched on JD Health's platform, reinforcing its position as the "first station for new specialty drug launches" [3] - JD Health has established strategic partnerships with companies like Novo Nordisk and Roche to enhance service offerings in chronic disease management [3][4] Service Integration and User Experience - JD Health is enhancing its "medical, testing, diagnosis, and medication" service loop to meet diverse health needs [5] - The company has developed a five-specialty system focusing on dermatology, mental health, traditional Chinese medicine, oncology, and andrology [5] - The average daily consultation volume for JD Internet Hospital exceeded 500,000 as of June 30, 2025 [5] Home Healthcare Services - JD Health is expanding its home healthcare services, with the JD Nurse at Home service covering 64 service items across seven categories [6] - The company has linked over 200,000 pharmacies nationwide for its instant delivery service [4][6] AI and Technological Innovation - JD Health is leveraging AI to enhance clinical decision-making and health management, with over 50 million users served by its AI products [7] - The company has launched the "JD AI" series, which includes various AI-driven professional services for users and healthcare providers [7] - A partnership with Wenzhou Medical University Hospital has resulted in an AI-driven outpatient service process that has served over 2.2 million patients [7]

Core Insights - JD Health reported a total revenue of RMB 35.3 billion for the first half of 2025, representing a year-on-year growth of 24.5%, with a Non-IFRS net profit of RMB 3.57 billion, up 35% [1] - The company has surpassed 200 million annual active users and has over 150,000 third-party merchants on its platform [1] - JD Health is enhancing its supply chain capabilities and solidifying its position as the leading online health consumption platform [1][3] Financial Performance - Total revenue for the first half of 2025 reached RMB 35.3 billion, a 24.5% increase compared to the previous year [1] - Non-IFRS net profit was RMB 3.57 billion, reflecting a 35% year-on-year growth [1] User Engagement and Market Position - As of June 30, 2025, JD Health has over 200 million annual active users and more than 150,000 third-party merchants [1][3] - The average daily consultation volume at JD Internet Hospital exceeded 500,000 [5][6] Supply Chain and Product Offerings - JD Health is strengthening its omni-channel supply chain capabilities, collaborating with leading pharmaceutical companies to expand product offerings [3] - The company launched over 30 innovative drugs online, reinforcing its position as the first stop for new specialty drugs [3][4] Service Integration and Healthcare Model - JD Health is enhancing its "medical, testing, diagnosis, and medication" service loop, focusing on personalized health needs [5][6] - The company has developed a five-specialty system in areas such as dermatology and mental health, providing tailored treatment plans [6] Technological Innovation - JD Health is leveraging AI technology to enhance healthcare services, with over 50 million users served by its AI products [7] - The company has introduced AI-driven solutions for both patients and healthcare professionals, improving service efficiency [7] Social Responsibility and Market Trends - JD Health is actively involved in social responsibility initiatives, supporting rare disease patients and disaster relief efforts [8] - The company is positioned to capitalize on the growing health consumption market as public health awareness increases [8] Future Outlook - JD Health aims to deepen its omni-channel layout and enhance the accessibility of health products and services [9] - The company plans to expand its professional resources and further integrate AI applications in healthcare services [9]

Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5% [2] - The Non-IFRS net profit reached 3.57 billion yuan, showing a year-on-year increase of 35% [2] User Engagement and Partnerships - As of the end of June, JD Health's annual active user count exceeded 200 million [2] - The number of third-party partner merchants surpassed 150,000 [2] - JD Internet Hospital achieved an average daily consultation volume of over 500,000 [2] Strategic Developments - JD Health strengthened its omnichannel supply chain capabilities to enhance the accessibility of pharmaceutical and health products, solidifying its position as the "first entry point for online health consumption" [2] - The company is continuously improving its "medical + testing + diagnosis + medication" service loop, promoting the integration of online and offline service formats to meet diverse and personalized health needs [2] - With the trend of deep integration of AI in industry applications, JD Health focuses on practical scenario value, achieving large-scale implementation of AI products across multiple scenarios, leading the transformation of medical intelligence in China [2]

依托"AI京医"的升级，京东互联网医院的服务效率和体验均有显著提升。一方面，通过专家医生智能体与AI诊疗助手的协同，医生的接 诊响应速度进一步优化；另一方面，借助京东健康"医、检、诊、药"闭环服务，用户与AI的互动不仅仅是简单的咨询问答，更重要的是 满足后链路需求，比如可以直接在线完成医药健康产品购买、检查预约等服务，真正享受到"一站式体验"。截至2025年6月30日，"AI京 医"智能体累计服务用户数已超5000万，覆盖看病买药的线上全流程、全场景。 此外，京东健康还发布了业内首个医院全场景应用AI产品——京东卓医(JOY DOC)，通过构建"个人就医管家""医生数字分身"和"未来数 字医院"，致力于让患者看病更舒心、医生临床科研更高效、医院整体运营更轻松。目前，"京东卓医"已在多家医疗机构落地。其中，京 东健康与温州医科大学附属第一医院合作打造的、基于AI驱动的门诊患者服务流程闭环，已累计服务患者超220万人次。 未来，京东健康将进一步推动AI应用的更大规模落地，以人工智能技术驱动服务模式创新，致力于让医疗健康服务变得更智能、更普 惠。 上半年，京东健康发布了应用于线上全场景的"AI京医"系列产品，包括面 ...

北京商报讯（记者 王寅浩 实习记者 宋雨盈）8月14日，京东健康发布公告称，2025年上半年实现营业 收入352.9亿元，同比增长24.5%；归属于公司所有者的期间盈利25.96亿元，同比增加27.45%。 ...

Core Insights - JD Health reported a total revenue of 35.3 billion yuan for the first half of 2025, representing a year-on-year growth of 24.5% [1] - The Non-IFRS net profit reached 3.57 billion yuan, showing a year-on-year increase of 35% [1] - The number of annual active users on JD Health's platform exceeded 200 million as of June 30, 2025 [1] Revenue and User Growth - JD Health's revenue growth is attributed to the enhancement of its self-operated, online platform, and instant retail channels [1] - The platform has over 150,000 merchants as of June 30, 2025 [1] Service Expansion and Innovations - JD Health's instant retail business has linked over 200,000 pharmacies nationwide, expanding online medical insurance payment services to nearly 200 million people [1] - The company is exploring innovative service models for retail pharmacies, including a collaboration with Beijing Children's Hospital to establish a pediatric pharmacy model [1] Healthcare Service Integration - JD Health has developed a comprehensive service loop covering "medical, testing, diagnosis, and medication" through its internet hospital [2] - The average daily consultation volume for JD Internet Hospital exceeded 500,000 as of June 30, 2025 [2] Home Healthcare Services - The home nursing service has expanded to cover 64 service items across 7 categories, including home care and traditional Chinese medicine care [2] - JD Health has also expanded its rapid testing service network, offering over 160 rapid testing services to users in 23 cities [2] AI Integration in Healthcare - JD Health launched the AI Jingyi series products for online scenarios, including AI doctors, pharmacists, nutritionists, and psychological consultants [2] - The AI Jingyi intelligent agents have served over 50 million users, enhancing the online health management experience [2]